Genetic variants reshape the m6A epitranscriptome and drive transcriptomic reprogramming in colorectal cancer

PABPN1-C5 axis promotes hepatocellular carcinoma progression via NF-κB activation

Pathogenic mechanism and therapeutic intervention of impaired N7-methylguanosine (m7G) tRNA modification

NAT10-mediated ac4C tRNA modification promotes EGFR mRAN translation and gefitinib resistance in cancer

N7-methylguanosine tRNA modification promotes esophageal squamous cell carcinoma tumorigenesis via the RPTOR/ULK1/autophagy axis.

The mRNA m6A reader YTHDF2 suppresses proinflammatory pathways and sustains hematopoietic stem cell function

Deciphering the molecular mechanisms of epitranscriptome regulation in cancer

Diverse molecular functions of m6A mRNA modification in cancer

Molecular Mechanisms Driving mRNA Degradation by m6A Modification

mRNA circularization by METTL3–eIF3h enhances translation and promotes oncogenesis

The m6A Methyltransferase METTL3 Promotes Translation in Human Cancer Cells

eIF4AIII enhances translation of nuclear cap-binding complex–bound mRNAs by promoting disruption of secondary structures in 5′UTR

Pioneer round of translation occurs during serum starvation

Pioneer round of translation mediated by nuclear cap-binding proteins CBP80/20 occurs during prolonged hypoxia

Exon junction complex enhances translation of spliced mRNAs at multiple steps